Menu

OncoCyte Corporation OCX

Full chart Compare
Set alert

Price alert · OCX

All alert types
3.20 0.00 (+0.00%)

At closeJun 17, 2025, 4:00 PM EDT

2.82 Day range 3.20

52-week range unavailable

YTD
+34.45%
1 year
+15.94%

Revenue & Expenses

Other Income → Expenses: $199.00KExpenses → Selling, General & Admin: $14.15MExpenses → Research & Development: $9.84MExpenses → Other Operating Expenses: $37.79MExpenses → Interest Expense: $84.00KGross Profit → Expenses: $740.00KRevenue → Gross Profit: $740.00KRevenue → Cost of Revenue: $1.14MNet Loss → Expenses: $60.93MOther Income$199.00KGross Profit$740.00KNet Loss$60.93MCost of Revenue$1.14MExpenses$61.87MSelling, General & Admin$14.15MResearch & Development$9.84MOther Operating Expenses$37.79MInterest Expense$84.00KRevenue$1.88M

Latest period ending Dec 31, 2024 · select a line to chart its full history

Annual income statement

OCX annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
1.88M1.50M958.00K2.20M1.22M
1.88M1.50M958.00K2.20M1.22M
1.14M1.09M976.00K778.00K1.85M
740.00K413.00K-18.00K1.42M-639.00K
61.78M25.55M17.98M55.15M29.07M
9.84M9.29M7.30M5.04M9.80M
14.15M13.98M23.01M22.84M23.28M
-61.04M-25.14M-18.00M-53.73M-29.71M
84.00K52.00K83.00K209.00K252.00K
-60.93M-28.72M-72.90M-64.10M-29.93M
-60.93M-28.72M-73.42M-64.10M-29.93M
-60.93M-28.72M-73.42M-64.10M-29.93M
-60.66M-27.78M-72.90M-64.10M-29.93M
263.00K942.00K000
-4.66-3.75-13.25-14.40-9.20
-4.66-3.75-13.25-14.40-9.20
-4.66-3.75-13.25-14.40-9.20
-60.84M-28.67M-72.82M-73.15M-30.93M
-60.84M-28.67M-72.82M-73.15M-30.93M
13.07M7.65M5.54M4.45M3.27M
13.07M7.65M5.54M4.45M3.27M